South Korea
· Delayed Price · Currency is KRW Skin n Skin Statistics
Total Valuation
Skin n Skin has a market cap or net worth of KRW 28.69 billion. The enterprise value is 29.85 billion.
| Market Cap | 28.69B |
| Enterprise Value | 29.85B |
Important Dates
The next estimated earnings date is Wednesday, November 13, 2024.
| Earnings Date | Nov 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Skin n Skin has 36.18 million shares outstanding. The number of shares has decreased by -4.10% in one year.
| Shares Outstanding | 36.18M |
| Shares Change (YoY) | -4.10% |
| Shares Change (QoQ) | -1.22% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 3.91% |
| Float | 24.04M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.79 |
| PB Ratio | 1.86 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -4.41 |
| EV / Sales | 1.92 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.03 |
Financial Position
The company has a current ratio of 1.29, with a Debt / Equity ratio of 36.38.
| Current Ratio | 1.29 |
| Quick Ratio | 0.87 |
| Debt / Equity | 36.38 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.92 |
| Interest Coverage | -31.26 |
Financial Efficiency
Return on equity (ROE) is -33.90% and return on invested capital (ROIC) is -15.53%.
| Return on Equity (ROE) | -33.90% |
| Return on Assets (ROA) | -12.97% |
| Return on Capital (ROIC) | -15.53% |
| Revenue Per Employee | 197.03M |
| Profits Per Employee | -85.73M |
| Employee Count | 79 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 4.34 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +611.61% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | +611.61% |
| 50-Day Moving Average | 981.16 |
| 200-Day Moving Average | 772.48 |
| Relative Strength Index (RSI) | 36.82 |
| Average Volume (20 Days) | 357,581 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Skin n Skin had revenue of KRW 15.57 billion and -6.77 billion in losses. Loss per share was -192.42.
| Revenue | 15.57B |
| Gross Profit | 4.86B |
| Operating Income | -5.62B |
| Pretax Income | -6.22B |
| Net Income | -6.77B |
| EBITDA | -5.08B |
| EBIT | -5.62B |
| Loss Per Share | -192.42 |
Balance Sheet
The company has 4.28 billion in cash and 5.44 billion in debt, giving a net cash position of -1.16 billion or -32.14 per share.
| Cash & Cash Equivalents | 4.28B |
| Total Debt | 5.44B |
| Net Cash | -1.16B |
| Net Cash Per Share | -32.14 |
| Equity (Book Value) | 14.96B |
| Book Value Per Share | 425.26 |
| Working Capital | 2.31B |
Cash Flow
In the last 12 months, operating cash flow was -5.19 billion and capital expenditures -745.21 million, giving a free cash flow of -5.93 billion.
| Operating Cash Flow | -5.19B |
| Capital Expenditures | -745.21M |
| Free Cash Flow | -5.93B |
| FCF Per Share | -164.02 |
Margins
Gross margin is 31.20%, with operating and profit margins of -36.09% and -43.51%.
| Gross Margin | 31.20% |
| Operating Margin | -36.09% |
| Pretax Margin | -39.96% |
| Profit Margin | -43.51% |
| EBITDA Margin | -32.62% |
| EBIT Margin | -36.09% |
| FCF Margin | -38.12% |
Dividends & Yields
Skin n Skin does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.10% |
| Shareholder Yield | 4.10% |
| Earnings Yield | -24.26% |
| FCF Yield | -20.68% |
Stock Splits
The last stock split was on December 6, 2023. It was a reverse split with a ratio of 0.1.
| Last Split Date | Dec 6, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.1 |